Retatrutide 10mg
Original price was: $349.00.$209.00Current price is: $209.00.
Premium Grade >99% Purity.
Key Benefits of Retatrutide
- Facilitates significant weight reduction
- Improves insulin sensitivity
- Stimulates fat breakdown and supports energy expenditure
- Promotes fatty acid oxidation
- Suppresses appetite and enhances satiety
- Boosts insulin secretion in response to glucose intake
- Delays gastric emptying, contributing to reduced calorie intake
- Inhibits release of glucagon
- Signals the hypothalamus to promote feelings of fullness
- Lowers blood glucose levels
Retatrutide represents an important evolution beyond earlier therapies such as semaglutide, owing to its capacity to activate three distinct metabolic hormone receptors—GLP-1, GIP, and glucagon. Developed by Eli Lilly for the advanced management of obesity, type 2 diabetes, and non-alcoholic fatty liver disease, this peptide-based agent provides more comprehensive effects than single- or dual-agonist drugs.
By simultaneously engaging GLP-1 and GIP receptors, retatrutide supports robust insulin secretion and appetite regulation. Its concurrent action on the glucagon receptor amplifies energy expenditure and lipolysis, striking a metabolic balance that further enhances fat loss and glycemic control.
Clinical evidence from phase 2 trials demonstrates retatrutide's exceptional efficacy, achieving up to 24.2% average body weight reduction over 48 weeks, with additional improvements in HbA1c, lipid profiles, and liver fat for treated patients. Emerging data also suggests benefits in related conditions like polycystic ovary syndrome, although further research is required to confirm these effects.
